Following a brief overview of the pathophysiology of HAE, this paper will review all currently available therapies and new treatment approaches in development for HAE with C1 esterase inhibitor (C1-INH) deficiency. The gene discussed is SERPING1; the disease is hyperinsulinemic hypoglycemia, familial, 4.